Vanguard Group Inc Intellia Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NTLA
# of Institutions
312Shares Held
91.5MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$173 Million2.39% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$136 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$72.7 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$69.9 Million3.75% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$44.5 Million0.05% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.07B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...